These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7325041)

  • 1. Clinicopathological correlations in multiple sclerosis and related diseases.
    Waxman SG
    Adv Neurol; 1981; 31():169-82. PubMed ID: 7325041
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathology of demyelination and remyelination.
    Ludwin SK
    Adv Neurol; 1981; 31():123-68. PubMed ID: 7325040
    [No Abstract]   [Full Text] [Related]  

  • 3. Approaches to the development of pharmacological interventions in multiple sclerosis.
    Davis FA; Schauf CL
    Adv Neurol; 1981; 31():505-10. PubMed ID: 6275674
    [No Abstract]   [Full Text] [Related]  

  • 4. Why does remyelination fail in multiple sclerosis?
    Franklin RJ
    Nat Rev Neurosci; 2002 Sep; 3(9):705-14. PubMed ID: 12209119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membranes, myelin, and the pathophysiology of multiple sclerosis.
    Waxman SG
    N Engl J Med; 1982 Jun; 306(25):1529-33. PubMed ID: 7043271
    [No Abstract]   [Full Text] [Related]  

  • 6. [Regenerative capacity in multiple sclerosis].
    Lubetzki C
    Bull Acad Natl Med; 2008 Mar; 192(3):495-504; discussion 505-6. PubMed ID: 18819695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal protection in multiple sclerosis--a particular need during remyelination?
    Smith KJ
    Brain; 2006 Dec; 129(Pt 12):3147-9. PubMed ID: 17132643
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunobiology of oligodendrocytes in multiple sclerosis.
    Ruffini F; Chojnacki A; Weiss S; Antel JP
    Adv Neurol; 2006; 98():47-63. PubMed ID: 16400826
    [No Abstract]   [Full Text] [Related]  

  • 9. Remyelination is extensive in a subset of multiple sclerosis patients.
    Patrikios P; Stadelmann C; Kutzelnigg A; Rauschka H; Schmidbauer M; Laursen H; Sorensen PS; Brück W; Lucchinetti C; Lassmann H
    Brain; 2006 Dec; 129(Pt 12):3165-72. PubMed ID: 16921173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurobiological fundamentals of re-myelinogenesis in the central nervous system].
    Chekhonin VP; Davydovskaia MV; Lebedev SV; Demina TL; Dmitrieva TB; Gusev EI
    Vestn Ross Akad Med Nauk; 2003; (8):43-52. PubMed ID: 14524118
    [No Abstract]   [Full Text] [Related]  

  • 12. Axonal dysfunction in chronic multiple sclerosis: meltdown in the membrane.
    Waxman SG
    Ann Neurol; 2008 Apr; 63(4):411-3. PubMed ID: 18350590
    [No Abstract]   [Full Text] [Related]  

  • 13. Alteration of the extracellular matrix interferes with raft association of neurofascin in oligodendrocytes. Potential significance for multiple sclerosis?
    Maier O; van der Heide T; van Dam AM; Baron W; de Vries H; Hoekstra D
    Mol Cell Neurosci; 2005 Feb; 28(2):390-401. PubMed ID: 15691718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?
    Williams A; Piaton G; Aigrot MS; Belhadi A; Théaudin M; Petermann F; Thomas JL; Zalc B; Lubetzki C
    Brain; 2007 Oct; 130(Pt 10):2554-65. PubMed ID: 17855378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schwann cells and their precursors for repair of central nervous system myelin.
    Kocsis JD; Waxman SG
    Brain; 2007 Aug; 130(Pt 8):1978-80. PubMed ID: 17626033
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasticity in the ontogeny and pathophysiology of myelinated fibers.
    Waxman SG
    Adv Neurol; 1981; 31():69-92. PubMed ID: 7325049
    [No Abstract]   [Full Text] [Related]  

  • 17. The aetiology and pathogenesis of multiple sclerosis.
    Adams CW; Hallpike JF
    Guys Hosp Rep; 1969; 118(2):263-86. PubMed ID: 4896181
    [No Abstract]   [Full Text] [Related]  

  • 18. Remyelination capacity of the MS brain decreases with disease chronicity.
    Goldschmidt T; Antel J; König FB; Brück W; Kuhlmann T
    Neurology; 2009 Jun; 72(22):1914-21. PubMed ID: 19487649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects of cell therapy for disorders of myelin.
    Ben-Hur T; Goldman SA
    Ann N Y Acad Sci; 2008 Oct; 1142():218-49. PubMed ID: 18990129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
    Wilczak N; Chesik D; Hoekstra D; De Keyser J
    Neurochem Int; 2008 Jun; 52(8):1431-5. PubMed ID: 18471934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.